<DOC>
	<DOCNO>NCT01976247</DOCNO>
	<brief_summary>The purpose study compare safety effectiveness Zeltiq System LipoSonix System fat reduction improve body shape .</brief_summary>
	<brief_title>A Pilot Study Testing Noninvasive Cryolipolysis Device Versus High Intensity Focused Ultrasound Device Fat Reduction</brief_title>
	<detailed_description>At baseline visit , subject meet inclusion exclusion criterion enrol . Subjects randomly assign receive Zeltiq treatment either right leave flank The contralateral flank receive Liposonix treatment . A total three identical treatment complete monthly 3 consecutive month . Subjects return 4 week follow last treatment follow photography , measurement , assessment . This study pilot study design determine feasibility procedure .</detailed_description>
	<criteria>1 . Female subject age 3065 year old . 2 . Body mass index ( BMI ) 18 29.99 . ( BMI define weight pound multiply 703 divide square height inch ) . 3 . Subjects good health . 4 . Willing able abstain partake treatment study procedure ( exist new ) promote body contour and/or weight loss course study participation . 5 . Subjects agree maintain weight ( i.e . within 5 pound ) make change diet lifestyle study . 6 . The subject willingness ability understand provide inform consent use tissue communicate investigator . 1 . Pregnant lactate intend become pregnant next 9 month . 2 . Unable understand protocol give inform consent . 3 . Any previous and/or pending procedure treatment area may likely affect treatment area . 4 . Pending and/or anticipated major change diet exercise pattern six week follow last treatment take diet pill within last 6 months.. 5 . History asthma chronic obstructive pulmonary disease . 6 . Active skin disease skin infection treatment area . 7 . Bleeding tendency coagulopathy . 8 . Subjects allergic lidocaine . 9 . Any condition would , professional opinion investigator , potentially affect response participation clinical study , would pose unacceptable risk subject .</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>